ScoreComparison
Why is Cytori Cell Research Institute, Inc. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -233.54% of over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 3.16% signifying low profitability per unit of shareholders funds
2
The company has declared positive results in Jun'2026 after 8 consecutive negative quarters
- NET SALES(Q) Highest at JPY 57.73 MM
- RAW MATERIAL COST(Y) Fallen by -72.91% (YoY)
- DEBT-EQUITY RATIO (HY) Lowest at -255.13 %
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -9.28%, its profits have fallen by -1649%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -9.28% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Cytori Cell Research Institute, Inc. should be less than 10%
- Overall Portfolio exposure to Realty should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Realty)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Cytori Cell Research Institute, Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Cytori Cell Research Institute, Inc.
-8.41%
-0.89
17.21%
Japan Nikkei 225
45.04%
1.48
29.43%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-36.50%
EBIT Growth (5y)
-233.54%
EBIT to Interest (avg)
-6.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
3.16%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
69.26
EV to EBIT
-8.94
EV to EBITDA
-9.53
EV to Capital Employed
28.20
EV to Sales
59.06
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-315.30%
ROE (Latest)
-2098.43%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend29What is working for the Company
NET SALES(Q)
Highest at JPY 57.73 MM
RAW MATERIAL COST(Y)
Fallen by -72.91% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -255.13 %
OPERATING PROFIT(Q)
Highest at JPY -91.82 MM
OPERATING PROFIT MARGIN(Q)
Highest at -159.05 %
PRE-TAX PROFIT(Q)
Highest at JPY -93.2 MM
NET PROFIT(Q)
Highest at JPY -93.67 MM
-9What is not working for the Company
NET PROFIT(HY)
At JPY -552.96 MM has Grown at -47.92%
ROCE(HY)
Lowest at -268.68%
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.71 times
CASH AND EQV(HY)
Lowest at JPY 193 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.2 times
Here's what is working for Cytori Cell Research Institute, Inc.
Net Sales
At JPY 57.73 MM has Grown at 352.88%
over average net sales of the previous four periods of JPY 12.75 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (JPY MM)
Net Sales
Highest at JPY 57.73 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (JPY MM)
Operating Profit
Highest at JPY -91.82 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Operating Profit Margin
Highest at -159.05 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at JPY -93.2 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Pre-Tax Profit
At JPY -93.2 MM has Grown at 62.4%
over average net sales of the previous four periods of JPY -247.91 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Net Profit
Highest at JPY -93.67 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
Net Profit
At JPY -93.67 MM has Grown at 62.18%
over average net sales of the previous four periods of JPY -247.67 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
Debt-Equity Ratio
Lowest at -255.13 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -72.91% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Cytori Cell Research Institute, Inc.
Inventory Turnover Ratio
Lowest at 0.71 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Cash and Eqv
Lowest at JPY 193 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 3.2 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Footer loading
